Table 4.
Secondary Outcomes
| Outcome | N (%) | 90% Confidence Interval | Details | 
|---|---|---|---|
| Cutaneous neonatal lupus | 4/63 (6.4%) | 2.2% - 13.9% | Occurred at 3, 5, 6 and 12 weeks after birth | 
| Weights below normal gestational age (<±2 standard deviations) | 1/63 (1.6%) | 0.08% - 7.3% | Born to a mother with SLE/SS weight=1.995 kg at 37 weeks | 
| Premature birth | 9/63 (14.3%) | 7.7% - 23.6% | |
| Premature rupture of membranes | 2/9 | 35 weeks, SLE/SS; 35 weeks, UAS | |
| Low amniotic fluid & intrauterine growth restriction | 2/9 | 35 weeks, SLE/SS; 35 weeks, UAS | |
| Pre-eclampsia | 1/9 | 36 weeks, SLE | |
| Placental insufficiency | 1/9 | 32 weeks, SLE | |
| Placental abruption | 1/9 | 35 weeks, SS | |
| Partial placenta previa with recurrent bleeding | 1/9 | 35 weeks, SLE/SS | |
| Vaginal bleeding of unknown cause | 1/9 | 36 weeks, UAS | 
SLE=systemic lupus erythematosus; SS=Sjogren’s syndrome; UAS=undifferentiated autoimmune syndrome